Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02071979 · ClinicalTrials.gov registry record · NA
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
A NA study, sponsored by Arteriocyte.
- Terminated
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
NCT02071979 is a NA study that was terminated before completion, run by Arteriocyte. The registered enrollment target is 1,500 participants.
The verdict
NCT02071979, a NA study, was terminated before completion, sponsored by Arteriocyte.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
Study Summary
This study will examine differences in the process of wound-healing in patients treated with platelet rich plasma (a concentration of proteins derived from a patients own blood) applied to the wound as a gel; injected into the wound or surrounding tissue; or both; compared to patients treated with usual medical treatment . This study seeks to enroll patients who are 18 or older with a non-healing skin wound that is at least 30 days old. Only patients with Diabetic Foot Ulcers, Venous Ulcers, or Pressure Ulcers will be included in the study.
Interventions
- DEVICE Autologous PRP Gel
- DEVICE Autologous PRP Injections
- DEVICE Autologous PRP Gel plus PRP Injections
- PROCEDURE Standard Wound Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02071979
The ClinicalTrials.gov registry entry for NCT02071979 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arteriocyte, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Autologous PRP Gel is the first listed.
NCT02071979 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02071979 about?
NCT02071979 is a clinical study titled "Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds". This study will examine differences in the process of wound-healing in patients treated with platelet rich plasma (a concentration of proteins derived from a patients own blood) applied to the wound as a gel; injected into the wound or surrounding tissue; or both; compared to patients treated with u...
What is the current status of trial NCT02071979?
This trial is currently terminated. It is a NA study. The enrollment target is 1,500 participants. The study started on 2014-04.
What interventions are being tested in trial NCT02071979?
The interventions under investigation include: Autologous PRP Gel (DEVICE), Autologous PRP Injections (DEVICE), Autologous PRP Gel plus PRP Injections (DEVICE), Standard Wound Care (PROCEDURE).
Who is sponsoring clinical trial NCT02071979?
This trial is sponsored by Arteriocyte, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.